Get the Stockscreener App
12.66
0.16%
-0.02
After Hours:
12.66
Integra Lifesciences Holdings Corp stock is traded at $12.66, with a volume of 1.19M.
It is down -0.16% in the last 24 hours and down -27.03% over the past month.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
See More
Previous Close:
$12.68
Open:
$12.49
24h Volume:
1.19M
Relative Volume:
1.21
Market Cap:
$983.81M
Revenue:
$1.53B
Net Income/Loss:
$40.23M
P/E Ratio:
25.32
EPS:
0.5
Net Cash Flow:
$60.93M
1W Performance:
+2.93%
1M Performance:
-27.03%
6M Performance:
-48.49%
1Y Performance:
-58.90%
1-Day Range:
$12.13
$12.82
1-Week Range:
$12.13
$13.31
52-Week Range:
$11.60
$32.66
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Name
Integra Lifesciences Holdings Corp
Sector
Industry
Phone
(609) 275-0500
Address
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
12.66 | 955.86M | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
133.58 | 228.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
105.26 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.64 | 143.93B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.98 | 103.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.22 | 43.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Upgrade | Argus | Hold → Buy |
| Dec-02-24 | Initiated | Morgan Stanley | Underweight |
| Oct-07-24 | Upgrade | BTIG Research | Sell → Neutral |
| Jul-30-24 | Downgrade | BTIG Research | Neutral → Sell |
| Jul-30-24 | Downgrade | Citigroup | Neutral → Sell |
| May-07-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-03-24 | Upgrade | Citigroup | Sell → Neutral |
| Dec-05-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-23 | Initiated | CL King | Buy |
| Aug-24-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-08-23 | Downgrade | Argus | Buy → Hold |
| May-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Downgrade | Citigroup | Neutral → Sell |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-25-22 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Dec-17-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-15-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-08-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-27-20 | Initiated | Citigroup | Neutral |
| Apr-03-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-03-19 | Initiated | SunTrust | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-07-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-18 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Neutral |
| Jan-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-30-17 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-27-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| May-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-13-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-06-17 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Dec-12-16 | Initiated | UBS | Buy |
View All
Integra Lifesciences Holdings Corp Stock (IART) Latest News
Is the Options Market Predicting a Spike in Integra LifeSciences Stock? - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - GlobeNewswire Inc.
3 Reasons to Sell IART and 1 Stock to Buy Instead - Yahoo Finance
American Airlines, Omnicell, Integra LifeSciences, Enovis, and Warby Parker Shares Are Soaring, What You Need To Know - Yahoo Finance
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by BNP Paribas Financial Markets - Defense World
Bank of America Corp DE Has $13.42 Million Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives Average Recommendation of “Reduce” from Analysts - Defense World
Northern Trust Corp Acquires 80,090 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences expands equity incentive plan By Investing.com - Investing.com Canada
Integra LifeSciences expands equity incentive plan - Investing.com
JMP Securities Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - Defense World
Integra Lifesciences (IART): Analyst Lowers Price Target to $25 | IART Stock News - GuruFocus
Integra LifeSciences stock target cut to $25 by JMP - Investing.com South Africa
Integra LifeSciences (IART) Sees Lowered Price Target Amid Marke - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cable One, Inc. - GlobeNewswire Inc.
JPMorgan Chase & Co. Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - Defense World
Wells Fargo & Company Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - Defense World
U.S. Regenerative Artificial Skin Market 2025-2032: Top Trends - openPR.com
Integra LifeSciences (NASDAQ:IART) Shares Gap Down Following Weak Earnings - Defense World
Integra LifeSciences (IART) Faces Adjusted Price Target Amid Rev - GuruFocus
Integra LifeSciences (IART) Faces Adjusted Price Target Amid Revenue Concerns | IART Stock News - GuruFocus
JP Morgan Adjusts Price Target for Integra Lifesciences (IART) | - GuruFocus
Wells Fargo Lowers Price Target for Integra Lifesciences (IART) - GuruFocus
JP Morgan Adjusts Price Target for Integra Lifesciences (IART) | IART Stock News - GuruFocus
Wells Fargo Lowers Price Target for Integra Lifesciences (IART) | IART Stock News - GuruFocus
Integra LifeSciences Holdings First Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Integra Q1 Earnings Miss Estimates, Stock Down, '25 EPS Outlook Cut - Nasdaq
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2025 Earnings Call Transcript - Insider Monkey
Stock Hits Across The Board As Companies Adjust Expectations - Finimize
Attention Long-Term Shareholders of Integra LifeSciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office is Inv - GlobeNewswire
Wells Fargo Adjusts Integra LifeSciences (IART) Price Target | I - GuruFocus
Wells Fargo Adjusts Integra LifeSciences (IART) Price Target | IART Stock News - GuruFocus
Raymond James Financial Inc. Makes New Investment in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra Lifesciences Holdings Corp (IART) Q1 2025 Earnings Call Highlights: Navigating ... - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Q1 2025 Earnings Call - GuruFocus
Integra LifeSciences (IART) Reports Q1 2025 Results and Strategi - GuruFocus
Integra: Q1 Earnings Snapshot - MySA
Integra Lifesciences Q1 2025 Earnings: Adjusted EPS of $0.41 Bea - GuruFocus
Integra LifeSciences (IART) Q1 Earnings: Misses EPS, Exceeds Rev - GuruFocus
Integra LifeSciences (IART) Reports Q1 Revenue Surpassing Expectations | IART Stock News - GuruFocus
Integra LifeSciences (IART) Reports Q1 2025 Results and Strategic Moves - GuruFocus
Why Integra LifeSciences (IART) Shares Are Getting Obliterated Today - Yahoo Finance
Integra LifeSciences Q1 2025 Earnings Call Transcript - MarketBeat
Long-Term Shareholders Have Rights – If You Hold Akero - GlobeNewswire
Long-Term Shareholders Have Rights – If You Hold Akero Therapeutics, Inc. (NASDAQ: AKRO); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); or Virtu Financial Inc. (NASDAQ: VIRT), Contact Grabar La - TradingView
Earnings call transcript: Integra LifeSciences misses Q1 2025 targets, stock plunges - Investing.com
Integra Lifesciences Holdings Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Integra LifeSciences misses Q1 estimates, shares fall 4% - Investing.com
Integra LifeSciences misses Q1 estimates, shares fall 4% By Investing.com - Investing.com Canada
Integra LifeSciences Slashes FY25 Adj. EPS OutlookUpdate - Nasdaq
Integra Lifesciences Holdings Corp Stock (IART) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.36%
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):